Mycophenolate Mofetil (MMF) Pharmacokinetic Profiles and Dosage Modification in Pediatric Kidney Transplant Patients

被引：0
|
作者：
Chadha, V. [1 ]
Vansickle, J. [1 ]
Jensen, C. [1 ]
Warady, B. [1 ]
机构：
[1] Childrens Mercy Hosp, Kansas City, MO 64108 USA
来源：
PEDIATRIC NEPHROLOGY | 2016年 / 31卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
PO-586
引用
收藏
页码：1952 / 1953
页数：2
相关论文
共 50 条
  • [21] CONVERSION OF MYCOPHENOLATE MOFETIL (MMF) TO ENTERIC COATED MYCOPHENOLATE SODIUM (EC-MPS) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Matsuda-Abedini, Mina
    Kiang, Tony K. L.
    Ensom, Mary H. H.
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 131 - 131
  • [22] Differences in pharmacokinetic profiles between long-term kidney/pancreas and non-diabetic kidney transplant patients on tacrolimus and mycophenolate mofetil.
    Cantarovich, M
    Paraskevas, S
    Keith, D
    Lipman, M
    Mangel, R
    Fontaine, G
    Metrakos, P
    Tchervenkov, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 331 - 331
  • [23] Mycophenolate mofetil (MMF) oral suspension in pediatric renal transplantation
    Sherbotie, J
    Bunchman, T
    Navarro, M
    Broyer, M
    Chavers, B
    Tonshoff, B
    Grimm, P
    Lemer, G
    Lirenman, D
    Greenbaum, L
    Walker, R
    Zimmerhackl, L
    Blowey, D
    Clark, G
    Ettenger, R
    Ramos, E
    TRANSPLANTATION, 1999, 67 (07) : S125 - S125
  • [24] Mycophenolate mofetil (MMF) long term results in pediatric transplantation
    Wiesel, M
    Adams, J
    Toenshoff, B
    JOURNAL OF UROLOGY, 2003, 169 (04): : 483 - 483
  • [25] Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil
    Mourad, M
    Malaise, J
    Eddour, DC
    De Meyer, M
    König, J
    Schepers, R
    Squifflet, JP
    Wallemacq, P
    CLINICAL CHEMISTRY, 2001, 47 (01) : 88 - 94
  • [26] Pharmacokinetic, -dynamic and clinical variability of mycophenolate mofetil in pediatric kidney transplantation.
    Goebel, Jens
    Logan, Barbara
    Maseck, Denise
    DeRotte, Maurits
    Tarabishi, Ridwan
    Vinks, Sander
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 59 - 59
  • [27] A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients
    Kremers, HM
    Funch, DP
    Robson, RA
    Nalesnik, MA
    Ebrahim, S
    Cecka, MJ
    Opelz, G
    Dreyer, NA
    Walker, AM
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1999, 8 (07) : 509 - 518
  • [28] Does mofetil mycophenolate (MMF) delay hepatitis C recurrence in liver transplant patients?
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Molmenti, EP
    Klintmalm, GB
    TRANSPLANTATION, 2000, 69 (08) : S120 - S120
  • [29] Pharmacokinetic monitoring of mycophenolate mofetil in de novo kidney-transplant patients receiving belatacept or cyclosporine A
    Kamar, Nassim
    Ribes, David
    Lavit, Michel
    Esposito, Laure
    Lavayssiere, Laurence
    Cointault, Olivier
    Salvin, Sylvie
    Durand, Dominique
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2007, 20 : 118 - 118
  • [30] Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients
    Aigrain, EJ
    Shaghaghi, EK
    Baudouin, V
    Popon, M
    Loirat, C
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (02) : 388 - 390
12345